| 摘要 |
<p>Disclosed is a use of 5-amino-1-beta-D-(5-benzylamino-5-deoxy-1-beta-D-ribofuranosyl)imidazole-4-carboxamide, 5-amino-1-(5-amino-5-deoxy-beta-D-ribofuranosyl) imidazole-4-N-[(4-chlorophenyl)methyl]carboxamide, or a salt thereof in the manufacture of a medicament for reducing the incidence of mortality in patients in need thereof, wherein said patients have decreased left ventricular function having an ejection fraction that is less than 30%, the medicament is also suitable for treating a patient with decreased left ventricular function having an ejection fraction that is less than 30%.</p> |
